Abstract
Because of its relatively low toxicity, acyclovirs will be prescribed widely for herpes simplex infections. Now is the time to address the potential problem of drug resistance in order to devise an appropriate strategy for drug use that will benefit the most patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 404-406 |
| Number of pages | 3 |
| Journal | Annals of internal medicine |
| Volume | 98 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 1983 |